Profile
Sheila Ranganath is Senior Vice President at Flagship Pioneering, Inc. since 2024.
Formerly, Dr. Ranganath was Vice President- Biology at LifeMine Therapeutics, Inc. from 2021 to 2022, Director at Merck & Co., Inc. from 2019 to 2021, Director at Enumeral Biomedical Holdings, Inc. in 2016, and Principal at Pfizer Inc. in 2011.
Education includes a doctorate from the University of Washington and an undergraduate degree from the University of California.
Sheila Ranganath active positions
| Companies | Position | Start |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 31/03/2022 |
Former positions of Sheila Ranganath
| Companies | Position | End |
|---|---|---|
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs from fungi which aims to cure untreatable and significant chronic diseases | Private Equity Investor | 01/03/2022 |
| MERCK & CO., INC. | Private Equity Investor | 01/04/2021 |
| ENUMERAL BIOMEDICAL HOLDINGS INC | Private Equity Investor | 01/08/2016 |
| PFIZER INC. | Corporate Officer/Principal | 01/04/2011 |
Training of Sheila Ranganath
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Enumeral Biomedical Holdings, Inc.
Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs from fungi which aims to cure untreatable and significant chronic diseases | Health Technology |
- Stock Market
- Insiders
- Sheila Ranganath
















